Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Generic probabilistic modelling and non-homogeneity issues for the UK epidemic of COVID-19

View ORCID ProfileAnatoly Zhigljavsky, Roger Whitaker, Ivan Fesenko, Kobi Kremnizer, Jack Noonan, Paul Harper, Jonathan Gillard, Thomas Woolley, Daniel Gartner, Jasmine Grimsley, Edilson de Arruda, Val Fedorov, Tom Crick
doi: https://doi.org/10.1101/2020.04.04.20053462
Anatoly Zhigljavsky
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anatoly Zhigljavsky
  • For correspondence: zhigljavskyaa{at}cardiff.ac.uk
Roger Whitaker
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan Fesenko
†University of Nottingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kobi Kremnizer
‡University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack Noonan
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Harper
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Gillard
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Woolley
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Gartner
*Cardiff University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasmine Grimsley
§ONS Data Science, Newport
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edilson de Arruda
¶Federal University of Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val Fedorov
‖Icon Clinical Research, Philadelphia, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Crick
**Swansea University
MBE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Coronavirus COVID-19 spreads through the population mostly based on social contact. To gauge the potential for widespread contagion, to cope with associated uncertainty and to inform its mitigation, more accurate and robust modelling is centrally important for policy making.

We provide a flexible modelling approach that increases the accuracy with which insights can be made. We use this to analyse different scenarios relevant to the COVID-19 situation in the UK. We present a stochastic model that captures the inherently probabilistic nature of contagion between population members. The computational nature of our model means that spatial constraints (e.g., communities and regions), the susceptibility of different age groups and other factors such as medical pre-histories can be incorporated with ease. We analyse different possible scenarios of the COVID-19 situation in the UK. Our model is robust to small changes in the parameters and is flexible in being able to deal with different scenarios.

This approach goes beyond the convention of representing the spread of an epidemic through a fixed cycle of susceptibility, infection and recovery (SIR). It is important to emphasise that standard SIR-type models, unlike our model, are not flexible enough and are also not stochastic and hence should be used with extreme caution. Our model allows both heterogeneity and inherent uncertainty to be incorporated. Due to the scarcity of verified data, we draw insights by calibrating our model using parameters from other relevant sources, including agreement on average (mean field) with parameters in SIR-based models.

We use the model to assess parameter sensitivity for a number of key variables that characterise the COVID-19 epidemic. We also test several control parameters with respect to their influence on the severity of the outbreak. Our analysis shows that due to inclusion of spatial heterogeneity in the population and the asynchronous timing of the epidemic across different areas, the severity of the epidemic might be lower than expected from other models.

We find that one of the most crucial control parameters that may significantly reduce the severity of the epidemic is the degree of separation of vulnerable people and people aged 70 years and over, but note also that isolation of other groups has an effect on the severity of the epidemic. It is important to remember that models are there to advise and not to replace reality, and that any action should be coordinated and approved by public health experts with experience in dealing with epidemics.

The computational approach makes it possible for further extensive scenario-based analysis to be undertaken. This and a comprehensive study of sensitivity of the model to different parameters defining COVID-19 and its development will be the subject of our forthcoming paper. In that paper, we shall also extend the model where we will consider different probabilistic scenarios for infected people with mild and severe cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The work is based on simulations only and described in the paper.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted April 15, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Generic probabilistic modelling and non-homogeneity issues for the UK epidemic of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Generic probabilistic modelling and non-homogeneity issues for the UK epidemic of COVID-19
Anatoly Zhigljavsky, Roger Whitaker, Ivan Fesenko, Kobi Kremnizer, Jack Noonan, Paul Harper, Jonathan Gillard, Thomas Woolley, Daniel Gartner, Jasmine Grimsley, Edilson de Arruda, Val Fedorov, Tom Crick
medRxiv 2020.04.04.20053462; doi: https://doi.org/10.1101/2020.04.04.20053462
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Generic probabilistic modelling and non-homogeneity issues for the UK epidemic of COVID-19
Anatoly Zhigljavsky, Roger Whitaker, Ivan Fesenko, Kobi Kremnizer, Jack Noonan, Paul Harper, Jonathan Gillard, Thomas Woolley, Daniel Gartner, Jasmine Grimsley, Edilson de Arruda, Val Fedorov, Tom Crick
medRxiv 2020.04.04.20053462; doi: https://doi.org/10.1101/2020.04.04.20053462

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)